DEF 14A

Company

CATALYST PHARMACEUTICALS, INC.

Filed

March 30, 2015

Period of Report

May 21, 2015

Accession Number

0001193125-15-111873

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →